Abstract
The reactivity of islet cell cytoplasmic antibodies (ICA)-positive and ICA-negative sera of recent onset type 1 diabetic patients was studied in human fetal pancreata of 12–18 weeks' gestation and compared with the reactivity of these sera in adult human control pancreata. The aims of the study were: (1) to observe the presence of ICA staining in human fetal islet cells; (2) to compare endpoint titres (in Juvenile Diabetes Foundation units) of ICA-positive patient sera in fetal pancreata and adult human control pancreata. Ten ICA-positive sera and eight ICA-negative sera from newly diagnosed diabetic patients and four sera from healthy controls were tested on three human adult and eight human fetal pancreata. As in the adult control pancreata. ICA-positive sera reacted to insulin-, glucagon-, and somatostatin-positive cells of fetal pancreata of all gestational ages. This was observed both in single cells and in cells in islet-like cell clusters. Dilution of a reference serum gave similar results in both adult and fetal pancreata. In contrast, the ICA-positive patient sera yielded a striking heterogeneity in fetal as well as in adult pancreata. However, end-point titres between adult and fetal pancreata did not differ significantly (P>0.05). In conclusion, ICA-positive sera from recent onset diabetic patients show that the expression of molecules to which ICA react is present in all islet cells and starts before week 12 of gestation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bruining GJ, Molenaar JM, Grobbee DE, Hofman A, Scheffer GJ, Bruining HA, De Bruyn AM, Valkenburg HA, Ten-year follow-up study of islet cell antibodies and childhood diabetes mellitus. Lancet: 1100–1103, 1989
Atkinson MA, Kaufman DL, Newman D, Tobin AJ, MacLaren NK, Islet cell cytoplasmic autoantibody reactivity to glutamate decarboxylase in insulin-dependent diabetes. J Clin Invest 91:350–356, 1993
Greenbaum C, Palmer J, Nagataki S, Yamaguchi Y, Molenaar JL, Van Beers WAM, MacLaren NK, Lernmark Å, and participating laboratories, Improved specificity of ICA assays in the fourth international immunology of diabetes serum exchange workshop. Diabetes 41:1570–1574, 1992
Nayak RC, Omar AK, Rabizadeh A, Srikanta S, Eisenbarth GS, Cytoplasmic islet cell antibodies: evidence that the target antigen is a sialoglyco-conjugate. Diabetes 34:617–619, 1985
Colman PG, Nayak RC, Campbell IL, Eisenbarth GS, Binding of cytoplasmic islet cell antibodies is blocked by human pancreatic glycolipid extracts. Diabetes 37:645–652, 1988
Pietropaolo M, Castaño L, Babu S, Buelow R, Kuo YL, Martin S, Martin A, Powers AC, Prochazka M, Naggert J, Leiter EH, Eisenbarth GS, Islet cell autoantigen 69 kD (ICA69). Molecular cloning andcharacterization of a novel diabetes-associated autoantigen. J Clin Invest 92:359–371, 1993
Genovese S, Bonifacio E, McNally JM, Dean BM, Wagner R, Bosi E, Gale EAM, Bottazzo GF, Distinct cytplasmic islet cell antibodies with different risks for type I (insulin-dependent) diabetes mellitus. Diabetologia 35:385–388, 1992
Adams TE, Alpert S, Hanahan D, Non-tolerance and autoantibodies to a transgenic self antigen expressed in pancreatic beta cells. Nature 325:223–228, 1987
Sundkvist G, Bergqvist A, Weibull H, Bergqvist D, Fält K, Landin Olsson M, Lernmark Å, Islet cell antibody reactivity with human fetal pancreatic islets. Diabetes Res Clin Pract 14:1–8, 1991
RR Krijger de, Aanstoot HJ, Kranenburg G, Reinhard M, Visser WJ, Bruining GJ, The midgestational human fetal pancreas contains cells coexpressing islet hormones. Dev Biol 153:368–375, 1992
Bruining GJ, Molenaar J, Tuk CW, Lindeman J, Bruining HA, Marner B, Clinical time-course and characteristics of islet-cell cytoplasmic antibodies in childhood diabetes. Diabetologia 26:24–29, 1984
Palmer JP, Asplin CM, Clemons P, Lyen K, Tatpati O, Raghu PK, Paguette TL, Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 222:1337–1339, 1983
Wilkin T, Armitage M, Casey C, Pyke DA, Hoskin PJ, Rodier M, Diaz JC, Leslie RDG, Value of insulin auto-antibodies as serum markers for insulin-dependent diabetes mellitus. Lancet I:480–482, 1985
Madsen OD, Landin-Olsson M, Bille G, Sundkvist G, Lernmark Å, Dahlqvist G, Ludvigsson J, A two-colour immunofluorescence test with a monoclonal human proinsulin antibody improves the assay for islet cell antibodies. Diabetologia 29:115–118, 1986
Landin-Olsson M, Sundkvist G, Lernmark Å, Prolonged incubation in the two-colour immunofluorescence test increases the prevalence and titre of islet cell antibodies in Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 30:327–332, 1987
Bottazzo GF, Doniach D, Islet-cell antibodies (ICA) in diabetes mellitus. Evidence of an autoantigen common to all cells in the islet of Langerhans. Ric Clin Lab 8:29–39, 1978
Landin-Olsson M, Sundkvist G, Lernmark Å, Precision of isletcell antibody assay depends on the pancreas. Diabetologia 31:511(A), 1988
Nayak RC, Omar MAK, Rabizadeh A, Srikanta S, Eisenbarth GS, “Cytoplasmic” islet cell antibodies: evidence that the target antigen is a sialoglycoconjugate. Diabetes 28:617–619, 1985
McCulloch DK, Barmeier H, Neifing JL, Palmer JPP, Metabolic state of the pancreas affects end-point titre in the islet cell antibody assay. Diabetologia 34:622–625, 1991
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
de Krijger, R.R., van Krugten, M.V., Kranenburg, G. et al. Islet cell cytoplasmic antibody reactivity in midgestational human fetal pancreas. Acta Diabetol 31, 232–235 (1994). https://doi.org/10.1007/BF00571957
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00571957